Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenylephrine crossover decongestant study in seasonal allergic rhinitis
2005-004309-27Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of phenylephrine and pseudoephedrine in seasonal allergic rhinitis (SAR) (3 arms), sponsored by Merck & Co. Primary endpoint: Primary efficacy endpoint. Started Nov 2005; status: completed.
02
Drugs
phenylephrinepseudoephedrine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2005-004309-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004309-27.